Stock Price Quote

ALBERT DAVID LTD.

NSE : ALBERTDAVDBSE : 524075ISIN CODE : INE155C01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE1045.45-13.45 (-1.27 %)
PREV CLOSE ( ) 1058.90
OPEN PRICE ( ) 1060.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3367
TODAY'S LOW / HIGH ( )1036.00 1069.75
52 WK LOW / HIGH ( )508.35 1090.2
NSE1047.35-11.45 (-1.08 %)
PREV CLOSE( ) 1058.80
OPEN PRICE ( ) 1054.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 15912
TODAY'S LOW / HIGH( ) 1037.00 1072.40
52 WK LOW / HIGH ( )505.95 1092
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1938
Management Info
Arun Kumar Kothari - Chairman Umesh Manohar Kunte - Managing Director
Registered Office

Address D Block, 3rd Floor,Gillander House 8,Netaji Subhas Road,
Kolkata,
West Bengal-700001

Phone 033 22628436 / 8456 / 8492

Email albertdavid@adlindia.in

Website www.albertdavidindia.com

Registrars Details
Maheshwari Datamatics Pvt Ltd
23 RN Mukherjee Road, ,5th Floor (Old Address: 6 Mangaoe Lane 2nd Floor),,kokata
Listing : BSE, NSE

NEWS

15Nov Albert David informs about postal ball
Albert David has informed that it enclosed the copy of the Postal Ballot..
10Nov Albert David informs about press release
Albert David has informed that it enclosed the unaudited Financial Resul..
26Sep Albert David informs about closing of
In terms of the Code of Conduct to regulate, monitor and report Trading..
08Sep Albert David gets nod to invest upto R
Albert David has received approval for investment upto Rs 61.25 lakh in..
06Jan Albert David informs about loss of sha
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclo..

Financials

in Millions
QTR Sep 23 ANNUAL 23
Net Profit202.98361.75
Gross Profit 265.46 507.36
Operating Profit 280.63597.4
Net Sales 931.763415.64

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE)
peergroup  8215.50 (2.40%)
M.Cap ( in Cr)18920.81
Coral Laboratories (BSE)
peergroup  483.40 (16.45%)
M.Cap ( in Cr)172.70
Caplin Point Lab (BSE)
peergroup  1293.05 (3.16%)
M.Cap ( in Cr)9819.52
Gland Pharma (BSE)
peergroup  1807.45 (1.89%)
M.Cap ( in Cr)29769.05
Mankind Pharma (BSE)
peergroup  1917.20 (1.73%)
M.Cap ( in Cr)76800.82

Shareholding Pattern

PROMOTERS 62.04%
NON-INSTITUTION 35.48%
FI/BANKS/INSURANCE 1.89%
MUTUAL FUNDS/UTI 0.01%
GOVERNMENT 0%
FII 0%

About Albert David Ltd.

Albert David Ltd. was incorporated in the year 1938. Its today's share price is 1045.45. Its current market capitalisation stands at Rs 596.66 Cr. In the latest quarter, company has reported Gross Sales of Rs. 3605.89 Cr and Total Income of Rs.3569.61 Cr. The company's management includes AB Chakrabartty, Monjori Mitra, Shirish G Belapure, Shourya Sengupta, Rajiv Singhi, Hemal Kampani, Anand Vardhan Kothari, Prabhawati Devi Kothari, Umesh Manohar Kunte, Arun Kumar Kothari.

It is listed on the BSE with a BSE Code of 524075 , NSE with an NSE Symbol of ALBERTDAVD and ISIN of INE155C01010. It's Registered office is at D Block, 3rd Floor,Gillander House 8,Netaji Subhas RoadKolkata-700001, West Bengal. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Basu Chanchani & Deb, G Basu & Co, LB Jha & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.